- Sales: USD 586 million - an increase of 111% compared to the previous year
- Net income: USD 49.5 million (Q1 2024: USD 11.1 million).
- Adjusted EBITDA: USD 91.1 million (Q1 2024: USD 32.3 million).
- Number of subscribers: 2.4 million - growth of 38% compared to Q1 2024
- Monthly online revenue per user: USD 84 (up 53% compared to Q1 2024)
- Gross margin: 73% (compared to 82% in the same period of the previous year)
- Free cash flow: USD 50.1 million (Q1 2024: USD 11.9 million).
Outlook for 2025 (full year):
- Sales forecast: USD 2.3 to 2.4 billion.
- Forecast for adjusted EBITDA: USD 295 to 335 million.
Long-term targets until 2030:
- Sales: at least USD 6.5 billion.
- Adjusted EBITDA: at least USD 1.3 billion.
$HIMS (-1,68%) emphasizes its focus on personalized healthcare solutions, the expansion of new specialist areas and international expansion. The strong development and growing customer demand support the optimistic forecast.